Metraipolis › archive › dc_ea0ca2e7a706

Hybrid Mass Spectrometry Applied across the Production of Antibody Biotherapeutics — Europe PMC PMID:39573914

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39573914
DOI
10.1021/jasms.4c00253
License (as archived)
solo-consultazione
Archived
2026-10-17T15:46:18.479Z
SHA-256 of the archived text
fa76366f17c343867fc6af72aa6706a5a21af940bd2ea0db790d1596c83d08a7
Stable URL of this page
https://metraipolis.com/documento/dc_ea0ca2e7a706

How to cite

Hybrid Mass Spectrometry Applied across the Production of Antibody Biotherapeutics — Europe PMC PMID:39573914 — Europe PMC (en), https://europepmc.org/article/MED/39573914 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea0ca2e7a706 (Metraipolis archive dc_ea0ca2e7a706, sha256 fa76366f17c343867fc6af72aa6706a5a21af940bd2ea0db790d1596c83d08a7)
BibTeX
@misc{dcea0ca2e7a706,
  title = {Hybrid Mass Spectrometry Applied across the Production of Antibody Biotherapeutics — Europe PMC PMID:39573914},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39573914},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea0ca2e7a706; sha256 fa76366f17c343867fc6af72aa6706a5a21af940bd2ea0db790d1596c83d08a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39573914. Agents can read the archived copy with the MCP tool read_document.